Related references
Note: Only part of the references are listed.GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Qing-Ao Xiao et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation
Shuai Yuan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention
Ernesto S. Nakayasu et al.
CELL METABOLISM (2020)
GDF15 mediates the effects of metformin on body weight and energy balance
Anthony P. Coll et al.
NATURE (2020)
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Joerg Wischhusen et al.
FRONTIERS IN IMMUNOLOGY (2020)
GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness
Maria Conte et al.
FRONTIERS IN IMMUNOLOGY (2020)
Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis
Zhanyi Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Lasse Folkersen et al.
NATURE METABOLISM (2020)
PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations
Mihir A. Kamat et al.
BIOINFORMATICS (2019)
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Harding H. Luan et al.
CELL (2019)
Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort
Xue Bao et al.
DIABETOLOGIA (2019)
Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
Emily A. Day et al.
NATURE METABOLISM (2019)
Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice
Mohammad Reza Dorvash et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Association of circulating inflammation proteins and gallstone disease
Zhiwei Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
Marie Verbanck et al.
NATURE GENETICS (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert et al.
CLINICAL CHEMISTRY (2017)
Growth Differentiation Factor 15 as a Novel Biomarker for Metformin
Hertzel C. Gerstein et al.
DIABETES CARE (2017)
Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing
Lisa Schlender et al.
BMC GERIATRICS (2017)
Metformin Use Correlates with Reduced Risk of Gallstones in Diabetic Patients: A 12-Year Follow-up Study
Kuan-Fu Liao et al.
FRONTIERS IN PHARMACOLOGY (2017)
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
Simon J. Griffin et al.
DIABETOLOGIA (2017)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Gallstones
Frank Lammert et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
K. Chrysovergis et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
GDF15 Is a Novel Biomarker for Impaired Fasting Glucose
Jun Hwa Hong et al.
DIABETES & METABOLISM JOURNAL (2014)
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus
Jun Li et al.
PLOS ONE (2013)
Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome
Serhat Isik et al.
CLINICAL ENDOCRINOLOGY (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
The 1000 Genomes Project: data management and community access
Laura Clarke et al.
NATURE METHODS (2012)
Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets
Laurence Macia et al.
PLOS ONE (2012)
The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients
Greisa Vila et al.
CLINICAL CHEMISTRY (2011)
The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism
Samuel N. Breit et al.
GROWTH FACTORS (2011)
Diagnostic Validity of Serum Macrophage Inhibitor Cytokine and Tissue Polypeptide-Specific Antigen in Pancreatobiliary Diseases
Hasan Ozkan et al.
PANCREATOLOGY (2011)
Roles of Infection, Inflammation, and the Immune System in Cholesterol Gallstone Formation
Kirk J. Maurer et al.
GASTROENTEROLOGY (2009)
Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
James E. Everhart et al.
GASTROENTEROLOGY (2009)
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Heiko Johnen et al.
NATURE MEDICINE (2007)
Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
Flavio Nervi et al.
JOURNAL OF HEPATOLOGY (2006)
Share Paper
